Safety margin in irradiation of colorectal liver metastases: Assessment of the control dose of micrometastases

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Seidensticker, Max ^a   Wust, Peter ^b   Rühl, Ricarda ^a   Mohnike, Konrad ^a   Pech, Maciej ^a   Wieners, Gero ^a   Gademann, Günther ^a   Ricke, Jens ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GADOBENATE DIMEGLUMINE; GAMMAMED; IOPROMIDE; IRIDIUM 192; IRINOTECAN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; COLORECTAL CANCER; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION SAFETY; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; ADENOCARCINOMA; CANCER STAGING; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77952311387     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-24     Document Type: Article

References (32)

1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995, 19:59-71. 10.1007/BF00316981, 7740812.
2. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, Hoss A, Schlegel W, Wannenmacher MF. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001, 19:164-170.
3. Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001, 177:645-655. 10.1007/PL00002379, 11789403.
4. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007, 246:559-565. 10.1097/SLA.0b013e318155a7b6, 17893492.
5. Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by CT-guided HDR-brachytherapy. Int J Radiat Oncol Biol Phys 2010,
6. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001, 8:347-353. 10.1007/s10434-001-0347-3, 11352309.
7. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. Radiology 2004, 230:450-458. 10.1148/radiol.2302020646, 14688400.
8. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashio K, Furuya S, Nakajima N. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999, 42:632-639. 10.1007/BF02234142, 10344686.
9. Wray CJ, Lowy AM, Mathews JB, Park S, Choe KA, Hanto DW, James LE, Soldano DA, Ahmad SA. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 2005, 12:374-380. 10.1245/ASO.2005.06.038, 15915371.
10. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318. 10.1097/00000658-199909000-00004, 1420876, 10493478.
11. Nagashima I, Oka T, Hamada C, Naruse K, Osada T, Muto T. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. Am J Gastroenterol 1999, 94:739-743. 10.1111/j.1572-0241.1999.00945.x, 10086660.
12. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997, 84:1077-1080. 10.1002/bjs.1800840810, 9278644.
13. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, Ike H, Oki S, Hara M. Micrometastatic colorectal cancer lesions in the liver. Surg Today 1998, 28:707-713. 10.1007/BF02484616, 9697263.
14. Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, Hirohashi S. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer 2000, 89:267-275. 10.1002/1097-0142(20000715)89:2<267::AID-CNCR10>3.0.CO;2-1, 10918155.
15. Isono T, Miyazaki M, Nakajima T, Okui K, Kondo Y. Clinicopathological significance of intrahepatic micrometastases in hepatic metastatic carcinomas. Nippon Geka Gakkai Zasshi 1990, 91:1778-1783.
16. Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, Ajioka Y, Hatakeyama K. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol 2008, 15:2472-2481. 10.1245/s10434-008-0023-y, 18594929.
17. Buffa FM, Fenwick JD, Nahum AE. An analysis of the relationship between radiosensitivity and volume effects in tumor control probability modeling. Med Phys 2000, 27:1258-1265. 10.1118/1.599003, 10902554.
18. Buffa FM, West C, Byrne K, Moore JV, Nahum AE. Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. Int J Radiat Oncol Biol Phys 2001, 49:1109-1118. 10.1016/S0360-3016(00)01533-9, 11240253.
19. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G, Spors B, Werk M, Rosner C, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004, 58:1496-1505. 10.1016/j.ijrobp.2003.09.024, 15050329.
20. Pech M, Spors B, Wieners G, Warschewske G, Beck A, Cho C, Fischbach F, Ricke J. Comparison of different MRI sequences with and without application of Gd-BOPTA as follow-up after LITT. Rofo 2004, 176:550-555.
21. Okano K, Maeba T, Moroguchi A, Ishimura K, Karasawa Y, Izuishi K, Goda F, Usuki H, Wakabayashi H, Maeta H. Lymphocytic infiltration surrounding liver metastases from colorectal cancer. J Surg Oncol 2003, 82:28-33. 10.1002/jso.10188, 12501166.
22. Yasui K, Hirai T, Kato T, Torii A, Uesaka K, Morimoto T, Kodera Y, Yamamura Y, Kito T, Hamajima N. A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 1997, 226:582-586. 10.1097/00000658-199711000-00002, 1191119, 9389391.
23. Herfarth KK, Debus J, Lohr F, Bahner ML, Fritz P, Hoss A, Schlegel W, Wannenmacher MF. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 2000, 46:329-335. 10.1016/S0360-3016(99)00413-7, 10661339.
24. Wulf J, Hadinger U, Oppitz U, Thiele W, Flentje M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol 2003, 66:141-150. 10.1016/S0167-8140(02)00372-9, 12648785.
25. Lange T, Wenckebach TH, Lamecker H, Seebass M, Hunerbein M, Eulenstein S, Gebauer B, Schlag PM. Registration of different phases of contrast-enhanced CT/MRI data for computer-assisted liver surgery planning: evaluation of state-of-the-art methods. Int J Med Robot 2005, 1:6-20.
26. Wybranski C, Seidensticker M, Mohnike K, Kropf S, Wust P, Ricke J, Ludemann L. In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiat Res 2009, 172:598-606. 10.1667/RR1773.1, 19883228.
27. Bru A, Albertos S, Subiza JL, Garcia-Asenjo JL, Bru I. The universal dynamics of tumor growth. Biophysical Journal 2003, 85:2948-2961. 10.1016/S0006-3495(03)74715-8, 1303573, 14581197.
28. Freyer JP, Sutherland RM. A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol 1985, 124:516-524. 10.1002/jcp.1041240323, 4044662.
29. Laird AK. Dynamics of Tumor Growth. British Journal of Cancer 1964, 18:490-502.
30. Turner GA, Weiss L. Some effects of products from necrotic regions of tumours on the in vitro migration of cancer and peritoneal exudate cells. Int J Cancer 1980, 26:247-254. 10.1002/ijc.2910260218, 6162807.
31. Kansal AR, Torquato S, Harsh GR, Chiocca EA, Deisboeck TS. Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. J Theor Biol 2000, 203:367-382. 10.1006/jtbi.2000.2000, 10736214.
32. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G, Spors B, Werk M, Rosner C, et al. CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 2004, 180:274-280. 10.1007/s00066-004-1179-4, 15127157.